# Module investigation

Status: active
Opened: 2026-09-29
Closed:

## Task

Please implement the approved plan at docs/plans/module-investigation.md -- This is explicit authorization\
to begin the substantive implementation task described by that plan

## Follow-ups

### Review disposition direction

The review is complete.  Assess and record a disposition for every finding. Act on findings whose resolution is clear and within the authorized scope. Ask me before rejecting or materially qualifying a finding, choosing between consequential alternatives, expanding scope, or proceeding where the reviewer identifies unresolved uncertainty.

### Review resolution choices

The human answered the following questions (question text is retained as context):

> F1: I agree replacement associations are misattributed. May I make each correction explicitly identify the subjects whose accounts it corrects, while using correction.target solely for the corrected investigram and never inferring corrected subjects from the originating request?

Use explicit corrected subjects (Recommended)

> F2: How should unusual provider usage be handled without failing the investigation? I recommend retaining each distinct report with explicit anomalies, excluding unresolved figures from trusted totals.

Retain reports with anomalies (Recommended)

> F4 needs your ruling: should delivering a correction's reason or qualifications create a citation to its reporting investigram, since corrections are its accompanying content?

Cite the reporting investigram (Recommended)

> F7 and the unexplained execution-ownership test cancellations contain unresolved uncertainty. May I investigate them with bounded regression checks, preserving the current shared input-basis policy while testing README acquisition and comparing cancellation behavior against the pre-implementation baseline? I’ll report the evidence before proposing any policy change.

Investigate and report (Recommended)

### F7 acceptance and cancellation deferral — 2026-09-29

Re F7, I’ll accept your recommended disposition, with one clarification: this is a conservative shared acquisition basis, not an exact list of inputs used by the compiler. The behavior seems reasonable for this slice:

- Reading README registers it for session validity, as required.
- Advancing the shared revision makes incomplete mechanical work eligible for another attempt. That may be unnecessary work, but doesn’t misrepresent its outcome.
- Completed work remains reusable, and earlier records remain unchanged. The reported regression covers the important interaction. Including README in later input-basis records is acceptable provided that membership means “captured in the shared basis,” not “used to derive this mechanical claim.”



  Please record that distinction and the conservative retry behavior in the architecture account, then disposition F7 as accepted current behavior with regression coverage. Separating acquisition revisions by relevance could be a later optimization if unnecessary re-evaluation becomes significant; it needn’t expand this milestone.    ;;; Re deferring cancellation diagnosis: defer, deferral with:
  - A backlog entry containing the reproduction commands, baseline commit, affected tests, and captured results.
  - Milestone validation distinguishing the cancelled suite runs from the successful isolated runs.
  - Explicit disclosure in the review handoff, so the reviewer can assess whether the remaining uncertainty affects milestone acceptance.
  Please describe validation as qualified by this unresolved concern, rather than treating isolated passes as a fully passing suite.

### Round 2 review disposition direction — 2026-09-29

The next round of review is complete.  As usual:  Assess and record a disposition for every finding. Act on findings whose resolution is clear and within the authorized scope. Ask me before rejecting or materially qualifying a finding, choosing between consequential alternatives, expanding scope, or proceeding where the reviewer identifies unresolved uncertainty.

### Round 2 resolution choices — 2026-09-29

The human answered the following questions (question text is retained as context):

> R2-F1 requires an evidence-response contract change. May I return selected claims with their own qualification and evidence, summarize evaluation-level qualification by reference, and add bounded navigation through module/group/artifact listings? I’ll verify qualification preservation and usable relationship/documentation access at realistic scale, then prepare the correction for another independent review.

Implement scoped, navigable evidence (Recommended)

> For R2-F2, may I restrict correctedSubjects to module, symbol, group and repository-artifact records, rejecting claims, source-evidence and content captures? This keeps corrections associated with described subjects while evidence remains separately attributable.

Restrict to these subject kinds (Recommended)

### Round 3 review disposition direction — 2026-09-29

The next round of review is complete.  As usual:  Assess and record a disposition for every finding. Act on findings whose resolution is clear and within the authorized scope. Ask me before rejecting or materially qualifying a finding, choosing between consequential alternatives, expanding scope, or proceeding where the reviewer identifies unresolved uncertainty.

### Round 3 resolution choices — 2026-09-29

Context: the recommendations were lighter module listings retaining identity,
naming claim and qualification with source support available through inspectable
references, and separate summarized-evidence tracking in attempt reports and
accepted provenance. Summary citations retain their exposure form; references
alone remain uncitable.

Go ahead with both recommendations; of course with attendant regression coverage and architecture doc updates

### Milestone 1 acceptance — 2026-09-29

ok, Milestone 1 is accepted

### Milestone 2 implementation direction — 2026-09-29

Go ahead with milestone 2

### Milestone 2 round 1 review disposition direction — 2026-09-29

The review round is complete:  As usual:  Assess and record a disposition for every finding. Act on findings whose resolution is clear and within the authorized scope. Ask me before rejecting or materially qualifying a finding, choosing between consequential alternatives, expanding scope, or proceeding where the reviewer identifies unresolved uncertainty.

## Outcome

### Milestone 1 — domain execution checkpoint

Implemented at `d4260522c2abf0530de076c05944f531de003e4b` on
`codex/module-investigation`, against opening boundary
`c15afdd3b03f588534ac386c2453c81da71ffb68`. The task remains active, awaiting
the plan's human-arranged milestone-1 review and direction before milestone 2.

The evaluation-layer assessment found existing module, dependency and organization
evaluators already separate from projection construction and responsible for
their own reuse. Retain those evaluators and add a domain evidence-query boundary
over them; a wholesale evaluator rewrite would add risk without a needed change
in responsibility. Extend the existing provider with subject-based content
acquisition through its captured-input host, rather than introduce another
filesystem policy. This preserves the existing mechanical command path.

The domain interpretation boundary now coordinates fresh bounded dialogues,
qualified evidence/context requests, explicit submission, whole-result acceptance,
correction eligibility, immutable composition/replacements, provenance and
attempt usage. The agent communication boundary is exercised through a reusable
scripted double. Returned accepted units are not yet retained as session
interpretation outcomes; that is milestone 2. No CLI or externally meaningful
product capability changed, so the existing user reference and project status
remain applicable.

No dependency was added. The concrete hosted route, provider/model verification
and credential disclosure belong to milestone 3 and have not been selected or
exercised. No credentials were read and no repository content was transmitted to
an inference provider by PostCode. The implementation uses the plan's allowed
single explicit submission protocol without repair/truncation recovery; its
bounds and cancellation limits are documented in the
[architecture account](../../docs/architecture/investigation.md). The implementation
conventions now identify the reusable double and independent usage ownership.

The remaining milestones, live formative assessments, milestone reviews and final
integrated review remain required. This checkpoint does not conclude the task or
establish human acceptance of a review gate.

## Verification

### Milestone 1 review follow-up

The human-arranged [round-1 review](../reviews/module-investigation/2026-09-29-milestone-1-round-1-findings.md)
was assessed under the recorded follow-up direction. The
[disposition](../reviews/module-investigation/2026-09-29-milestone-1-disposition.md)
addresses every finding and preserves the non-defect observations and residual
uncertainties. F3, F5 and F6 were accepted and corrected in
`1de634a29e0ba07a42091d0718f286462f77e3f4`. F1 and F2 are accepted issues with
resolution choices awaiting human direction; F4 and F7 require the requested
ruling/investigation direction. The reviewer-reported test cancellations remain
unresolved and have not been dismissed. Milestone 2 has not begun.

The correction passed type checking, build, all 31 investigation tests and
`git diff --check`. No full-suite rerun or live inference was performed for these
corrections. The milestone gate remains unaccepted pending human direction.

### Approved review rulings and bounded investigation

The recorded human rulings were implemented in `f5a974d` and `32f90a5`:
corrections identify explicit corrected subjects, usage preserves distinct
reports with anomalies, and delivered correction content cites its reporter.
All F1–F6 findings are corrected. The F7 regression establishes the shared-basis
retry consequence without changing policy; acceptance of that behavior was
requested and remains pending.

The bounded comparison reproduced all 13 execution-ownership cancellations on
the pre-implementation baseline and the corrected full suite. Both isolated
runs passed 13 tests. Baseline full results were 283 passed, zero failed,
13 cancelled; corrected full results were 318 passed, zero failed, 13 cancelled.
The pattern is pre-existing; its cause remains unresolved. Human direction on
explicitly deferring diagnosis versus keeping it open was requested and remains
pending. No cancellation code or test was changed.

Type checking, build, all 34 investigation tests, and the README regression
passed. The final usage-report equality refinement passed both focused usage
tests after the full-suite run started. The
[correction validation](../validation/module-investigation/2026-09-29-milestone-1-review-corrections.md)
preserves the exact verification scope and limits. The updated disposition
records every finding; the original review remains unchanged. Milestone 2 has
not begun, and the human has not accepted the milestone-1 gate.

### F7 acceptance and qualified diagnosis deferral

The human accepted F7 with regression coverage and clarified that membership in
the conservative shared acquisition basis does not establish compiler use or
claim derivation. The architecture account now records that distinction and the
conservative eligibility for retry of incomplete work, with completed work and
earlier records preserved. Acquisition revisions by relevance remain a possible
later optimization, outside this milestone.

The human also deferred cancellation diagnosis subject to durable evidence and
explicit qualification. The backlog now contains the reproduction commands,
pre-implementation baseline, affected tests and captured results. The correction
validation distinguishes the cancelled full-suite runs from successful isolated
runs and explicitly remains qualified by the unresolved concern. A dated,
human-requested addendum to the original handoff discloses that evidence for the
reviewer's assessment of milestone acceptance. The original handoff text and
review findings remain unchanged. F1–F7 now have resolved dispositions, with
cancellation diagnosis deferred rather than explained or dismissed.

These documentation changes were checked with `git diff --check` and local link
target validation. No runtime code changed and no tests were rerun for this
follow-up. Earlier test results retain their stated qualifications. The task
remains active at milestone 1 pending the human's gate decision; milestone 2 has
not begun.

### Round 2 corrections ready for independent review

The human-approved R2-F1 and R2-F2 contracts are implemented in
`212fa9e82f58d41f3de6829ad84285e40305930b`. Evidence responses retain selected
claims and their own qualified support, summarize evaluation/repository-wide
qualification separately, and expose bounded stable continuation pages. Group
navigation reaches members, artifacts and documentation. Extensive own source
support can be separately inspected without making a subject disappear from the
population or treating bare references as supplied evidence. Corrected subjects
are restricted to modules, symbols, groups and repository artifacts.

The [disposition](../reviews/module-investigation/2026-09-29-milestone-1-disposition.md)
addresses both round-2 findings, all round-1 status confirmations, the process
observation and residual limits. The original findings and handoff remain
unchanged for this round. A further independent review of the changed evidence
contract is required under that handoff; the human arranges it. Milestone 2 has
not begun and this checkpoint does not accept the milestone gate.

Final type checking passed. `npm test` passed 339 tests with zero failures,
cancellations or skips. The [round-2 validation](../validation/module-investigation/2026-09-29-milestone-1-round-2-corrections.md)
records fixture regressions, provenance checks, the real-repository sweep and
reproduction commands. All 258 modules and 79 groups were navigable; all
relationship/export queries for 93 project modules stayed within collection
bounds with no omitted entries or unavailable responses, and group navigation
reached 595 artifacts including root README content. Explicit source-support
references remain distinct from embedded evidence. Whitespace and local link
checks passed.

The latest successful full run does not diagnose the intermittent
execution-ownership cancellations. The human-authorized backlog deferral and
qualified validation remain in force, with the previously cancelled suites and
successful isolated runs kept distinct. No cancellation code, runtime dependency,
CLI capability, governing material or development-process file changed. No
credentials or live inference were used.

### Original milestone 1 verification

Milestone 1: `npm run check` passed; `npm test` passed 323 tests. Subsequent
targeted checks covered the final local corrections: 62 investigation/store/input/
output-boundary tests, then 37 investigation/expansion tests and another type
check. `git diff --check` passed. The full suite preceded the final local
corrections; targeted final checks passed on the committed implementation.

The [validation record](../validation/module-investigation/2026-09-29-milestone-1.md)
records coverage, chronology, reproduction and limits. These are implementing-agent
checks, not independent review or evidence of live interpretive usefulness.

### Round 3 corrections complete

The human-approved R3-F1 and R3-F2 recommendations are implemented in
`aef0878b17e1d31ec079edecd63a8ada469f56f8`. Module listings retain naming claims
and full own qualification while delivering source support by inspectable
reference. Attempt reports and accepted provenance distinguish summaries from
fully supplied records, preserve both exposure forms when both were delivered,
and reject citations to uninspected references or withheld summaries. The
architecture and investigator instructions describe these semantics; the
investigation method advanced to version 5.

Type checking and build passed. All 342 tests passed with zero failures,
cancellations or skips; the final focused evidence suite passed all 10 tests.
The new 263-module regression completes a guarded inventory dialogue. On the
real repository, all 258 modules fit 21 pages; listing, one source inspection and
submission complete in 23 exchanges and 1,141,713 serialized units under the
unchanged limits. The complete collection sweep omitted no entries and returned
no unavailable collection responses. The
[round-3 validation](../validation/module-investigation/2026-09-29-milestone-1-round-3-corrections.md)
preserves reproduction, exact results, the corrected initial test assumption
and limits. Whitespace and local documentation links were checked.

Every finding has a disposition. The reviewer considers the third round
sufficient once its low-severity findings are corrected or dispositioned, without
a mandatory further independent round. Both are now corrected. The original
handoff and authored findings remain unchanged. Validation remains qualified by
the unresolved, explicitly deferred execution-ownership cancellation concern;
this passing run does not diagnose it. No hosted/live validation or milestone-2
implementation was undertaken. The task remains active at milestone 1 awaiting
the human's gate decision.

### Milestone 2 — shell and session integration checkpoint

Implemented in `a396f9b8e9b38ad344554cbe4c0e7677ded1ec0e`, against the accepted
milestone-1 boundary `bca53ba66b1440039de805e1d74e2ef9a10a552b`. The
[milestone-2 handoff](../reviews/module-investigation/2026-09-29-milestone-2-handoff.md)
and [validation record](../validation/module-investigation/2026-09-29-milestone-2.md)
are committed for human-arranged independent review.

The evaluation-layer organization now includes a dedicated investigation evaluator.
It owns operation-based reuse and atomic publication of accepted interpretation
and accompanying corrections into the existing program record store. Mechanical
evaluators remain responsible for their own reuse and acquisition; projections
consume retained outcomes without invoking investigation. This separation avoids
putting inference or retention decisions into rendering, while a session-owned
evidence-access instance preserves continuation lifetime.

The production shell and one-shot paths support summary selection, retained
outcomes, exact investigram inspection, source traceability and attempt/session
usage. A private operation-tagged worker bridge reaches the injected investigator
communication participant in the parent while compiler/evidence/retention work
remains in the worker. Parent-owned usage and exposure snapshots survive active
worker termination. Earlier retained accounts supply context to subsequent
operations; correction targets and replacements remain independently inspectable.
Original composition is unchanged, with replacement selection and reconsideration
display still reserved for milestone 5.

No provider dependency, hosted setup, credential mechanism or public test flag was
added. Regular CLI summary requests report configuration unavailability; tests
inject the scripted participant through the same worker/session path. Public
follow-up lenses and broader associated-account discovery remain later work.
Architecture, CLI reference, README and project status describe this checkpoint.
No governing foundation, development-process instruction or accepted decision was
modified.

Final type checking and build passed. The latest complete suite passed 360 tests
with no failures or cancellations (approximately 113.0 seconds). A final small
reporting refinement linked non-retained failures to their exact attempt and
labeled unknown aggregates in human final reporting; the final target then passed
all 18 integration tests (approximately 9.22 seconds) and all 13 isolated
execution-ownership tests (approximately 3.33 seconds), plus type checking,
whitespace and local documentation-link checks.

An intermediate complete run reproduced the deferred concern: 346 passed, zero
failed and 13 execution-ownership cancellations out of 359 tests, with the same
pending-promise/event-loop error. The validation, backlog and new handoff preserve
that result separately from the later full and isolated passes. Validation remains
qualified by the unresolved concern; no cancellation diagnosis or baseline rerun
was undertaken. Scripted tests establish integration behavior, not live provider
behavior or interpretive usefulness.

The overall task remains active at the milestone-2 review gate. The human arranges
independent review and determines acceptance before milestone 3. No milestone-3
implementation or live assessment has begun.
